Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | CHAT | P28329 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.43 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26918235 | 0.79 | IDO1 (0.57) | RELAMAOB | |
| SCHEMBL23443982 | 0.79 | IDO1 (0.57) | RELAMAOB | |
| SCHEMBL5871109 | 0.78 | NFE2L2 (0.36) | NFE2L2FBP1 | |
| SCHEMBL11101680 | 0.78 | IDO1 (0.61) | RELACHATCYP1A2CYP2C9NFE2L2 | |
| SCHEMBL11101682 | 0.78 | IDO1 (0.61) | RELACHATCYP1A2CYP2C9NFE2L2 | |
| SCHEMBL7697733 | 0.78 | RELA (0.47) | RELACHATCYP1A2CYP2C9NFE2L2 | |
| SCHEMBL256033 | 0.75 | CHAT (0.53) | RELACHATCYP1A2CYP2C9NFE2L2 | |
| SCHEMBL9131505 | 0.75 | CHAT (0.53) | RELACHATCYP1A2CYP2C9NFE2L2 | |
| SCHEMBL2097935 | 0.75 | RELA (0.45) | RELACHATCYP1A2CYP2C9NFE2L2 | |
| SCHEMBL2097937 | 0.75 | RELA (0.45) | RELACHATCYP1A2CYP2C9NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117355521-A | Heteroaryl inhibitors of plasma kallikrein | 武田药品工业株式会社 | 2024-01-05 | — | — | CN | disclosed |
| EP-2563123-A1 | NOVEL BETA 3 ADRENERGIC RECEPTOR AGONISTS | Merck Sharp & Dohme Corp. (US) | 2013-03-06 | — | — | EP | disclosed |